Arulraj Nadaradjane

Nantes, 44000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC.

Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC.

Journal: Scientific reports
Published: March 09, 2026

From AlphaFold to site-selective inhibition of DNA methylation in glioblastoma multiforme.

From AlphaFold to site-selective inhibition of DNA methylation in glioblastoma multiforme.

Journal: RSC medicinal chemistry
Published: November 04, 2025

Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMTmethylated/DGKImethylated glioblastoma.

Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMTmethylated/DGKImethylated glioblastoma.

Journal: Clinical epigenetics
Published: September 20, 2024

Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression.

Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression.

Journal: Cancers
Published: April 04, 2023

Radiotherapy-induced overexpression of exosomal miRNA-378a-3p in cancer cells limits natural killer cells cytotoxicity.

Radiotherapy-induced overexpression of exosomal miRNA-378a-3p in cancer cells limits natural killer cells cytotoxicity.

Journal: Epigenomics
Published: April 09, 2020

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme.

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme.

Journal: Molecular cancer
Published: October 04, 2019

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.

Journal: Cell death & disease
Published: July 25, 2019

Diuron exposure and Akt overexpression promote glioma formation through DNA hypomethylation.

Diuron exposure and Akt overexpression promote glioma formation through DNA hypomethylation.

Journal: Clinical epigenetics
Published: July 12, 2019

Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells.

Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells.

Journal: Cell death & disease
Published: May 28, 2019

N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool.

N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool.

Journal: Molecular therapy. Nucleic acids
Published: May 28, 2019

Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner.

Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner.

Journal: Frontiers in genetics
Published: April 29, 2019

miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker.

miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker.

Journal: Molecular therapy. Nucleic acids
Published: March 07, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026